The effectiveness of a comprehensive diabetes program for glycemic control and adherence, and the selection of candidates for sensor-augmented insulin pump therapy.
Diabetes mellitus tipo 1
Disease management
Gestión de la enfermedad
Glycated hemoglobin A1c
Hemoglobina glicosilada A1c
Logical models
Modelo lógico
Sensor-augmented insulin pump therapy
Terapia con bomba de insulina aumentada por sensor
Type 1 diabetes mellitus
Journal
Endocrinologia, diabetes y nutricion
ISSN: 2530-0180
Titre abrégé: Endocrinol Diabetes Nutr (Engl Ed)
Pays: Spain
ID NLM: 101717565
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
17
08
2020
accepted:
06
11
2020
entrez:
20
12
2021
pubmed:
21
12
2021
medline:
18
1
2022
Statut:
ppublish
Résumé
This study aimed to estimate the effectiveness of a comprehensive diabetes program (CDP) in terms of glycemic control, adherence, and the selection of candidates for sensor-augmented insulin pump therapy (SAP). We compared diabetes control before and 6 months after CDP. The program was based on disease management using a logical model dealing with the following: case management, education and coaching, nutritional assessment, and mental health. The CDP improved glycemic control, HbA1c decreased by 0.56% (p-value=0.004; 95% CI: 0.14-0.98) and 19.1% of the patients reached the HbA1c goal without hypoglycemia. The CDP reduced by 52.4% the indication for SAP due to better glycemic control (36.4%) or non-adherence issues (63.6%); the remaining 47.6% persisted with poor glycemic control despite good adherence and were scaled to SAP. Among the 30 suitable candidates for SAP therapy, 60% did not reach the HbA1c goal and 40% had either hypoglycemic episodes (severe or persistent) or dawn phenomenon. The overall non-adherence rate was 33.3%. CDP optimized the selection of suitable candidates for SAP by improving glycemic control and identifying adherence issues early. These results provide evidence of the impact of the implementation of patient selection and educational protocols in the real-life setting of a highly experienced clinic.
Identifiants
pubmed: 34924162
pii: S2530-0180(21)00163-3
doi: 10.1016/j.endien.2021.12.002
pii:
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
735-740Informations de copyright
Copyright © 2021 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.